当前位置: 首页 >> 检索结果
共有 6641 条符合本次的查询结果, 用时 6.6759486 秒

921. A Case of Labile BP in a Patient With Oropharyngeal Carcinoma.

作者: Jem Marie Golbin.;Albert Bui.;Michael Philippone.;Rendell Ashton.;Simon Mucha.
来源: Chest. 2024年166卷4期e105-e108页
A 71-year-old man with a history of recurrent tonsillar squamous cell carcinoma was admitted to the hospital with oropharyngeal bleeding. He received high-dose radiation therapy with curative intent. On day 4 of hospitalization, he demonstrated hypoxia resulting from an airway mucus plug and was brought to the medical ICU.

922. Tranexamic Acid Neurotoxicity After Nebulization and BAL.

作者: Jeremy Hardin.;Justin Seltzer.;Riku Moriguchi.;Kara Yeung.;Henrik Galust.;Bryan Corbett.;Aaron Schneir.;Richard F Clark.;Raymond T Suhandynata.
来源: Chest. 2024年166卷4期e101-e103页
Tranexamic acid is a commonly used hemostatic agent with broad clinical uses across multiple specialties. Systemic toxicity is due to gamma-aminobutyric acid type A and glycine receptor competitive antagonism and has been reported by multiple routes, but toxicity after pulmonary administration via nebulization and BAL has not yet been described. A 44-year-old man with a history of congenital pulmonary arteriovenous malformations underwent routine bronchoscopy for hemoptysis. He received preprocedure nebulized tranexamic acid 500 mg three times daily for 48 h. An additional 1,000 mg was given via BAL for intraprocedural hemostasis. One hour after the procedure, he developed altered mental status, myoclonus, and hyperthermia, which was ultimately controlled with propofol and vecuronium. As the use of pulmonary tranexamic acid increases, toxicity from this agent should be considered. Dose reductions and alternate treatment modalities should be considered in patients with advanced age, arteriovenous malformations, and renal insufficiency.

923. My Voice.

作者: Lilit A Sargsyan.
来源: Chest. 2024年166卷4期835-836页

924. Organizational Resilience: A Systems-Based Approach for Addressing the Workforce Crisis in Intensive Care.

作者: Mara Buchbinder.;Theodore J Iwashyna.;Olga Yakusheva.;Lesly A Kelly.;Deena K Costa.
来源: Chest. 2024年166卷4期673-675页

925. Unraveling the Healthy Adherer Effect in the Clinical Management of Sleep Apnea With CPAP.

作者: Sanjay R Patel.
来源: Chest. 2024年166卷4期671-672页

926. Are There Any New, Useful Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in Patients With Systemic Sclerosis?

作者: Antonietta Gigante.;Michał Ciurzyński.
来源: Chest. 2024年166卷4期668-670页

927. Measuring Diaphragm Blood Flow: A New Window Into Diaphragm Function.

作者: Catherine A Bellissimo.;Ewan C Goligher.
来源: Chest. 2024年166卷4期665-667页

928. ICU Staffing and Organization: Everything Has Changed.

作者: Andrew J Admon.;Meeta Prasad Kerlin.
来源: Chest. 2024年166卷4期661-662页

929. Delirium in the ICU: It's Time to Turn Down the Sedation.

作者: Stuti J Jaiswal.;Robert L Owens.
来源: Chest. 2024年166卷4期659-660页

930. Small Hinges That Swing Big Doors: Small Airways Obstruction and Death.

作者: Muhammad Faizyab Ali Chaudhary.;Sandeep Bodduluri.
来源: Chest. 2024年166卷4期657-658页

931. New Evidence for SARS-CoV-2 Vaccine Boosting in Patients With Chronic Lung Diseases.

作者: Laura Fabbri.;Stefan Cristian Stanel.
来源: Chest. 2024年166卷4期655-656页

932. The Lifelong Burden of Severe Childhood Asthma.

作者: Tara F Carr.
来源: Chest. 2024年166卷4期653-654页

933. The Growth of Screening-Detected Pure Ground-Glass Nodules Following 10 Years of Stability.

作者: Bo-Guen Kim.;Hyunseung Nam.;Inwoo Hwang.;Yoon-La Choi.;Jung Hye Hwang.;Ho Yun Lee.;Kyung-Mi Park.;Sun Hye Shin.;Byeong-Ho Jeong.;Kyungjong Lee.;Hojoong Kim.;Hong Kwan Kim.;Sang-Won Um.
来源: Chest. 2025年167卷4期1232-1242页
It remains uncertain for how long pure ground-glass nodules (pGGNs) detected on low-dose CT (LDCT) imaging should be followed up. Further studies with longer follow-up periods are needed to determine the optimal follow-up duration for pGGNs.

934. Gender Differences in Outcomes of Ambulatory and Hospitalized Patients With Obesity Hypoventilation Syndrome.

作者: Nathan C Nowalk.;Babak Mokhlesi.;Julie M Neborak.;Juan Fernando Masa Jimenez.;Ivan Benitez.;Francisco J Gomez de Terreros.;Auxiliadora Romero.;Candela Caballero-Eraso.;Maria F Troncoso.;Mónica González.;Soledad López-Martín.;José M Marin.;Sergi Martí.;Trinidad Díaz-Cambriles.;Eusebi Chiner.;Carlos Egea.;Isabel Utrabo.;Ferran Barbe.;Maria Ángeles Sánchez-Quiroga.
来源: Chest. 2025年167卷1期245-258页
Obesity hypoventilation syndrome (OHS) is associated with high morbidity and mortality. There are few data on whether there are gender differences in outcomes.

935. Graded Transthoracic Contrast Echocardiography After Pulmonary Arteriovenous Malformation Embolization: Can Chest CT Scan Be Avoided in Patients With a Low-Grade Shunt?

作者: Josefien Hessels.;Sjors Klompmaker.;Daniel A F van den Heuvel.;Sanne Boerman.;Hans-Jurgen Mager.;Marco C Post.
来源: Chest. 2025年167卷3期842-850页
Pulmonary arteriovenous malformations (PAVMs) are direct connections between the pulmonary artery and vein, creating a right-to-left shunt (RLS). Embolization is indicated to prevent complications. Guidelines recommend follow-up chest CT scans to confirm persistent occlusion and embolization of all treatable PAVMs. Graded transthoracic contrast echocardiography (TTCE) after PAVM embolization may offer a reliable alternative in a subgroup of patients while preventing radiation exposure.

936. Peak Inspiratory Flow and Inhaler Prescription Strategies in a Specialized COPD Clinical Program: A Real-World Observational Study.

作者: Sarah Pankovitch.;Michael Frohlich.;Bader AlOthman.;Jeffrey Marciniuk.;Joanie Bernier.;Dorcas Paul-Emile.;Jean Bourbeau.;Bryan A Ross.
来源: Chest. 2025年167卷3期736-745页
COPD inhaler regimens should be appropriate for the patient's peak inspiratory flow (PIF) and should ideally consist of single or similar device(s).

937. Understanding Nonpharmacologic Palliative Care for People With Serious COPD: The Individual and Organizational Perspective.

作者: Kristoffer Marsaa.;Mai-Britt Guldin.;Alda Marques.;Hilary Pinnock.;Daisy J A Janssen.
来源: Chest. 2025年167卷1期112-120页
This narrative review emphasizes the growing interest in palliative care for people with serious lung diseases such as COPD. It reflects on recent publications from the American Thoracic Society, the World Health Organization, and European Respiratory Society, with a focus on nonpharmacologic palliative care for people with COPD from both the health care professional and organizational perspective.

938. The Foundation Supporting Future Assessments of Education Program Outcomes Among Providers of Advanced Practice Respiratory Therapy.

作者: Robert Shaw.;David Vines.;Jennifer Benavente.;Shane Keene.
来源: Chest. 2025年167卷1期202-210页
There are physician shortages in the United States including in the cardiopulmonary specialty. Nonphysician advanced practice providers, including nurse practitioners or physician assistants, have been proposed to meet some more routine patient care needs. A supplementary provider called an advanced practice respiratory therapist (APRT) has been proposed. Such personnel start as respiratory therapists followed by training in a graduate degree program. The Commission on Accreditation for Respiratory Care has published a set of standards for such an education program, and one program has begun to train APRTs. The Commission on Accreditation for Respiratory Care requires each accredited program to publish its outcomes. The respiratory therapy credentialing board, the National Board for Respiratory Care, has undertaken stewardship of assessing APRT education program outcomes. The research question asks whether there is national support to develop a standardized assessment of graduates' performances near the end of an APRT education program. This paper describes methods used during this study of the nascent APRT role, which informed decisions of an advisory committee as they considered what content to assess and how to design the measurement instrument. The study exposed a set of survey-derived metrics about potential content signaling whether there was endorsement among physicians, nonphysician advanced practice providers, and APRT graduates. Metrics are described from these and other subgroups plus the committee's decisions are explained about what content to assess and how. Most of the surveyed content was endorsed for being part of the APRT role; therefore, the committee proceeded to make design decisions about the outcome assessment.

939. The Impact of Nintedanib Dosing on Clinical Outcomes: An Analysis of Real-World Data.

作者: Andrew H Limper.;Viengneesee Thao.;David A Helfinstine.;Lindsey R Sangaralingham.;Timothy M Dempsey.
来源: Chest. 2025年167卷3期800-805页

940. Relationship of Pulmonary Vascular Structure and Function With Exercise Capacity in Health and COPD.

作者: Sophie É Collins.;Miranda Kirby.;Benjamin M Smith.;Wan Tan.;Jean Bourbeau.;Stephanie Thompson.;Sean van Diepen.;Dennis Jensen.;Sanja Stanojevic.;Michael K Stickland.; .
来源: Chest. 2025年167卷2期402-413页
Although it is generally accepted that aerobic exercise training does not change lung structure or function, some work suggests that greater pulmonary vascular structure and function are associated with higher exercise capacity (peak rate of oxygen consumption [V˙o2peak]).
共有 6641 条符合本次的查询结果, 用时 6.6759486 秒